Onchilles Pharma
Peter Haberz is the Vice President of Corporate Development at Onchilles Pharma.
This person is not in any teams
Onchilles Pharma
Onchilles Pharma was founded on breakthrough research of a novel neutrophil pathway that when activated selectively and comprehensively kills cancer cells.